Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant Cytokeratin 5 antibody (AA 316-590)

This anti-Cytokeratin 5 antibody is a Rabbit Monoclonal antibody detecting Cytokeratin 5 in IHC and IHC (f). Suitable for Human.
Catalog No. ABIN7126615

Quick Overview for Recombinant Cytokeratin 5 antibody (AA 316-590) (ABIN7126615)

Target

See all Cytokeratin 5 (KRT5) Antibodies
Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))

Antibody Type

Recombinant Antibody

Reactivity

  • 147
  • 85
  • 57
  • 12
  • 11
  • 11
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 107
  • 54
  • 2
Rabbit

Clonality

  • 93
  • 70
Monoclonal

Conjugate

  • 73
  • 17
  • 12
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Cytokeratin 5 antibody is un-conjugated

Application

  • 102
  • 76
  • 47
  • 32
  • 30
  • 27
  • 18
  • 14
  • 13
  • 13
  • 10
  • 9
  • 6
  • 5
  • 3
  • 2
  • 2
  • 1
  • 1
Immunohistochemistry (IHC), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Binding Specificity

    • 16
    • 16
    • 15
    • 11
    • 9
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 316-590

    Specificity

    This Mab recognizes a protein of 58 kDa, which is identified as Cytokeratin 5 (KRT5). This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. Antibodies to KRT5 identify basal cells of squamous and glandular epithelia, yoepithelial, and mesothelium.Anti-cytokeratin 5 has been reported useful in the differential diagnosis of metastatic carcinoma in the pleura versus epithelioid mesothelioma. Almost all squamous cell carcinomas, half of transitional carcinomas, and many undifferentiated large cell carcinomas express.Anti-KRT5, along with anti-p63, affords a high sensitivity and specificity for squamous differentiation. Myoepithelial cells of the breast, glandular epithelia, and basal cells of the prostate are labeled with anti-KRT5.

    Cross-Reactivity (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant fragment (around aa 316-590) of human Cytokeratin 5 (KRT5) protein (exact sequence is proprietary)

    Isotype

    IgG
  • Application Notes

    Known_Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human tonsil, esophagus or bladder tissue (IHC).

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Preservative

    Azide free

    Storage

    -20 °C,-80 °C

    Storage Comment

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Expiry Date

    24 months
  • Target

    Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))

    Alternative Name

    KRT5

    Background

    58 kDa Cytokeratin, DDD1, Epidermolysis Bullosa Simplex 2 (EBS2), Keratin 5, Keratin, Type II Cytoskeletal 5, Keratin-5, Type-II Cytoskeletal 5, Type-II keratin Kb5,Cytokeratin 5 (KRT5) (Basal, Myoepithelial & Mesothelial Cell Marker)
    Cellular localisation: Cytoplasmic

    Molecular Weight

    58kDa

    Gene ID

    3852, 433845

    UniProt

    P13647
You are here:
Chat with us!